Short Summary
The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 patent covering intravascular embolism treatment devices after finding Imperative Care’s likelihood of success on at least one claim. The decision centers on claim constructions of the “filament” element and obviousness over multiple prior‑art references.
Detailed Summary
In a Decision Granting Institution of Inter Partes Review, the Patent Trial and Appeal Board concluded that Imperative Care, Inc. has shown a reasonable likelihood of prevailing on at least one of the fifteen claims of Inari Medical’s U.S. Patent No. 11,554,005 B2, which claims a vacuum aspiration system with a hemostasis valve. The Board examined four statutory grounds, all under 35 U.S.C. § 103, relying on prior‑art references Garrison, Schaffer, Hartley, and Eller. A key dispute involved the term “filament,” where the petitioner defined it broadly, the patent owner emphasized flexibility, and the Board declined to limit the term for claim 1 while requiring flexibility for claim 10. Consequently, the IPR was instituted on all challenged claims, setting the stage for a full trial on obviousness and claim construction issues.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Imperative Care, Inc. vs Inari Medical, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
DISH Network L.L.C. et al.vsEntropic Communications, LLC
DISH Network seeks Director Review of a PTAB decision that denied institution of an IPR on its cable‑network patent, arguing the panel misapplied obviousness standards and acted inconsistently with a similar case.
Shenzhen Tuozhu Technology Co., Ltd. et al.vsStratasys, Inc. et al.
Shenzhen Tuozhu Technology has filed an IPR petition seeking to invalidate Stratasys' 3D‑printing patent covering RFID‑based material tagging, arguing obviousness over multiple prior‑art references and urging institution of the review.
GLOBALFOUNDRIES Inc. et al.vsOAK IP LLC
Globalfoundries and OAK IP settled their IPR dispute over U.S. Patent 9,905,691 before the Board instituted a trial. The settlement agreement was treated as confidential business information, and the proceeding was terminated.
Lenovo (United States) Inc. et al.vsHeadwater Research LLC
Court decision.
C.R. Bard, Inc. et al.vsMedline Industries, LP
C.R. Bard seeks an IPR of Medline’s ’347 patent covering urinary catheter trays, challenging claims 1‑8, 10‑11, 13‑20 as obvious over multiple prior‑art references. The petition argues that discretionary factors do not favor denial and requests institution.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.